Skip to main content
TipRanks
Go Ultimate75% OFF

Polygiene AB (POLYG) AI Stock Analysis

0 Followers
SE:POLYG

Polygiene AB

(Nasdaq OMX AB:POLYG)

Select Model
Rating:44Neutral
Price Target:SEK 2.50â–¼(-6.02% Downside)
Action:reiterated
Date:10/28/26

The score is held down primarily by weakened financial performance (TTM losses and negative free cash flow) and a bearish technical setup (below major moving averages with negative MACD). A strong, low-leverage balance sheet provides stability, but valuation is difficult to justify with a negative P/E and no dividend support in the provided data.

Positive Factors
Very low leverageThe conservative capital structure lowers refinancing and solvency risk while preserving financial flexibility. Stable equity relative to assets gives Polygiene more capacity to manage operating volatility and fund its specialized technology portfolio without relying heavily on external debt.
Negative Factors
Falling revenue and renewed operating lossesDeclining revenue combined with negative EBIT and net income signals that the current business base is not converting demand into sustainable profitability. Continued weakness would limit internal reinvestment, reduce operating leverage, and make recovery dependent on renewed growth or further cost discipline.

Polygiene AB (POLYG) vs. iShares MSCI Sweden ETF (EWD)

-80%-60%-40%-20%0%20%40%SE:POLYG-67.95%EWD+15.64%Dec '25Jan '26Feb '26Mar '26Apr '26May '26Jun '26Jul '26Aug '26Sep '26Oct '26Nov '26
Market Cap
SEK 97.16M
Dividend Yield
―
Average Volume (3M)
53.45K
Price to Earnings (P/E)
-22.3
Beta (1Y)
0.26
Revenue Growth
-18.26%
EPS Growth
35.77%
Country
Sweden
Employees
34
Sector
Basic Materials
Sector Strength
61
Industry
Chemicals - Specialty

Polygiene AB Business Overview & Revenue Model

Company Description

Based in Malmö, Sweden, and founded in 2005, Polygiene Group AB develops, produces, and markets advanced solutions designed to control odors and maintain freshness across a wide range of materials. These applications extend to clothing, athletic equi...

Polygiene AB Financial Statement Overview

Summary

Overall fundamentals are pressured: the income statement shows deteriorating profitability with TTM revenue down (-7.3%) and negative EBIT/net income, while cash flow is a major weakness with negative TTM operating cash flow and free cash flow. Offsetting this, the balance sheet is a clear strength with very low leverage and stable equity, reducing solvency risk but not fixing near-term earnings/cash burn.

Income Statement

41Neutral

Balance Sheet

82Very Positive

Cash Flow

33Negative
Financial statement breakdown
BreakdownTTMDec 2025Dec 2024Dec 2023Dec 2022Dec 2021
Income Statement
Total Revenue127.52M146.65M156.95M113.54M173.56M181.61M
Gross Profit48.04M48.32M103.78M77.16M114.57M115.24M
EBITDA-1.35M5.96M18.80M-304.02M20.34M43.99M
Net Income-4.29M-5.58M16.83M-321.95M8.36M32.83M
Balance Sheet
Total Assets307.06M304.74M350.84M313.78M621.90M550.69M
Cash, Cash Equivalents and Short-Term Investments34.20M38.78M68.59M44.15M48.06M52.40M
Total Debt2.02M4.57M2.63M3.89M1.64M2.40M
Total Liabilities19.91M28.56M31.23M22.53M29.34M31.54M
Stockholders Equity287.15M276.17M319.61M291.25M592.56M519.15M
Cash Flow
Free Cash Flow-5.62M-11.04M22.75M-4.27M-50.64M34.15M
Operating Cash Flow-4.13M-9.79M24.34M3.79M-1.54M37.60M
Investing Cash Flow-2.19M-4.07M-1.59M-9.42M-52.11M-407.47M
Financing Cash Flow-5.83M-9.67M-1.38M1.95M47.50M416.27M

Polygiene AB Technical Analysis

Technical Analysis SentimentNeutral
Last Price2.66

Price Trends

50DMA3.17Negative
100DMA3.91Negative
200DMA5.23Negative

Market Momentum

MACD-0.21Negative
RSI46.27Neutral
STOCH54.28Neutral

Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For SE:POLYG, the sentiment is Neutral. The current price of 2.66 is above the 20-day moving average (MA) of 2.65, below the 50-day MA of 3.17, and below the 200-day MA of 5.23, indicating a neutral trend. The MACD of -0.21 indicates Negative momentum. The RSI at 46.27 is Neutral, neither overbought nor oversold. The STOCH value of 54.28 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Neutral sentiment for SE:POLYG.

Polygiene AB Peers Comparison

Overall Rating

UnderperformOutperform
Sector (61)

Financial Indicators

SE:POLYG against its peers
NameOverall RatingMarket CapP/E RatioROEDividend YieldRevenue GrowthEPS Growth
SE:PCATSE:PCAT70OutperformSEK 19.18M5.13――-17.14%88.76%
SE:HPOL.BSE:HPOL.B68NeutralSEK 32.77B18.1212.33%4.41%-0.82%-7.46%
Sector *61Neutral$10.43B7.12-0.05%2.87%2.86%-36.73%
SE:SCA.ASE:SCA.A60NeutralSEK 85.02B39.412.14%2.48%-3.07%-38.98%
SE:ORGCSE:ORGC46NeutralSEK 80.80M-1.70-156.22%―-27.65%3.02%
SE:POLYGSE:POLYG44NeutralSEK 97.16M-22.30-1.52%―-18.26%35.77%
SE:NEXAMSE:NEXAM40UnderperformSEK 258.28M-12.35-9.37%―-4.57%-15.20%

* Basic Materials Sector Average

Performance Comparison

-50%0%50%100%SE:POLYGSE:HPOL.BSE:NEXAMSE:SCA.ASE:ORGCSE:PCATDec '25Jan '26Feb '26Mar '26Apr '26May '26Jun '26Jul '26Aug '26Sep '26Oct '26Nov '26
SE:POLYG and its peers over the selected period
Show on chartTickerCompany NamePriceChange% Change
SE:POLYGPolygiene AB2.66-5.64-67.95%
SE:HPOL.BHexpol AB95.1519.2425.34%
SE:NEXAMNexam Chemical Holding AB2.52-0.49-16.28%
SE:SCA.ASvenska Cellulosa Aktiebolaget Class A121.002.942.49%
SE:ORGCOrganoClick AB0.44-1.27-74.27%
SE:PCATPhotocat A/S3.20-0.60-15.79%
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.

Date of analysis: Oct 28, 2026